Unilever CLO Joins Sandoz Board Ahead Of Novartis Split
Swiss pharmaceutical company Sandoz, currently a division of multinational healthcare company Novartis, announced Monday it had named an in-house expert from consumer goods powerhouse Unilever to its newly formed board of...To view the full article, register now.
Already a subscriber? Click here to view full article